Tag Archives: PharmaceuticalLitigation

Xarelto Lawsuits Progress as Court Approves New Documents for Plaintiff Filing

The lawsuits concerning the pharmaceutical drug Xarelto picked up steam this past week as documents allowing for coordinated pretrial proceedings were approved in the U.S. District Court in Eastern Louisiana and in Pennsylvania’s Court of Common Pleas. As this blog has noted in the past, plaintiffs have asserted that the blood thinning drug causes uncontrollable bleeding, and that the bleeding caused by Xarelto cannot be reversed as with other blood thinners like Warfarin. A court order from March 24 will now allow new plaintiffs in the Louisiana litigation to file cases directly in the proceeding. The Pennsylvania court will allow plaintiffs to submit a Master Long Form Complaint to have their cases join the others that have already been filed. Both developments are signs that the lawsuits are moving forward and will probably continue to grow as more plaintiffs come forward. The coordination of the pretrial proceedings should make the…
Read More »

Posted in Pharmaceutical Litigation | Tagged , | Leave a comment

Six Percent Rise in Pradaxa Lawsuits, Consumers Suffering From Internal Bleeding

New court records reveal that the number of lawsuits alleging internal bleeding injury or death from taking dangerous drug Pradaxa has increased 6 percent since mid-October. Cases stemming from the dangerous drug have been consolidated to a special federal court in Illinois. The latest court records from the Judicial Panel on Multidistrict Litigation shows that the number of cases filed has increased over 6 percent in one month, increasing from 1,643 to 1,748. Pradaxa is a blood thinner that was approved by the Food and Drug Administration (FDA) in 2010. The defective drug is prescribed to patients with atrial fibrillation to prevent blood clots and stroke. The Institute for Safe Medication Practices has warned that patients may be nearly 5 times as likely to die from Pradaxa bleeding than from traditional blood thinner warfarin. This year, a European study discovered that patients taking anticoagulants like Pradaxa could be 55 percent…
Read More »

Posted in Pharmaceutical Litigation, Products Liability | Tagged , , | Leave a comment

OxyElite Pro Removed From US Stores after 29 Cases of Liver Failure

According to Hawaii News Now, drug manufacturer USPLabs is stopping US distribution of the diet pill OxyELITE Pro after a shocking number of liver failure cases connected to the supplement. Health experts have not figured out the exact reason why the diet pills are causing these devastating effects. OxyELITE Pro was distributed and sold all over the US, but all of the recent hospitalizations have occurred in Hawaii. USPLab’s announcement comes after the Hawaii Department of Health (DOH) requested the removal of OxyELITE Pro from Hawaii retailers, and asked consumers to stop any use of the drug. A total of 29 cases of liver failure and acute hepatitis have been reported in Hawaii in the last 6 months, all linked to dietary supplements. The FDA warned consumers earlier this year about supplements containing dimethylamylamine (including OxyELITE Pro) after it was linked to cases of serious illness and even death. I…
Read More »

Posted in Pharmaceutical Litigation, Products Liability | Tagged , , | Leave a comment

Studies Show Dramatic Increase in Pradaxa Lawsuits in Recent Months

There is new information out for patients taking the blood thinner Pradaxa. A recent court update shows the number of lawsuits alleging the drug caused internal injuries or death has risen nearly 30 percent in recent months. Pradaxa is a blood thinner approved by the Food and Drug Administration (FDA) in 2010 as a stroke preventative for patients with atrial fibrillation. The Institute for Safe Medication Practices has warned that patients may be nearly five times as likely to die from Pradaxa bleeding than from bleeding with warfarin, a traditional blood thinning medication. A study this year from the Netherlands suggests patients taking newer blood thinners like Pradaxa may be 55 percent more likely to suffer internal bleeding. A growing number of patients have filed Pradaxa lawsuits alleging internal bleeding, leading to the consolidation of cases in a federal multidistrict litigation court in Illinois. The latest court records show that…
Read More »

Posted in Class Action, Multidistrict Litigation, Pharmaceutical Litigation | Tagged | Leave a comment

Florida Pharmacist Sued for Mishandling Prescription

A 64-year-old woman filed suit against a pharmacist and his store in Winter Park, Florida, claiming the pharmacist gave her the wrong prescription for her rheumatoid arthritis. The pharmaceutical litigation names The Medicine Shoppe and its owner Mehrdad Hairi as defendants. Mr. Hairi is also a pharmacist. The woman alleges that in May 2009, she ordered her arthritis medication, methotrexate, through the mail. What she received was fluphenazine, an anti-psychotic drug used to treat schizophrenia. After taking the drug, she developed tremors, dizziness, blurred vision, cloudiness of thought and other maladies. She took the medication for three months before going to the emergency room. Another pharmacist discovered the prescription error when re-filling her methotrexate prescription. The plaintiff still experiences restlessness in her thigh, abnormal facial expressions, hand tremors and depression. Her lawsuit says that Hairi has faced accusations of mishandling prescriptions in the past in Florida. Records from the Florida…
Read More »

Posted in Personal Injury | Tagged | Leave a comment